Stock CYTO ALTAMIRA THERAPEUTICS
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Altamira Therapeutics Nasdaq

Equities

CYTO

BMG0360L2099

Market Closed - Nasdaq
Other stock markets
 16:30:00 2024-05-15 EDT 		5-day change 1st Jan Change
1.53 USD +6.25% Intraday chart for Altamira Therapeutics -8.86% -58.62%
05-01 Altamira Therapeutics Ltd. Announces Filing of Provisional Patent Application for OligoPhore Nanoparticles with siRNA Targeting p65 Protein in Treatment of Cancer and Inflammation CI
04-24 Altamira Therapeutics Ltd. Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal CI

Turnover - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

EBIT

  1. Stock Market
  2. Equities
  3. CYTO Stock
  4. CYTO Stock
  5. Revisions Altamira Therapeutics
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW